Joe Rogan Experience #2567 - Mariana van Zeller · Aired Oct 16, 2026
Claim summary · not a verbatim quotation
Joe says Rick Perry's brain scans showed age-related atrophy before ibogaine and none six months later.
The finding
What the evidence shows
Rogan's account matches what Perry himself says. A neuroscientist told Perry he had mild atrophy, and a neurosurgeon later looked at his before and after scans and said the atrophy was gone. But this is one person's report of his own scans. No scans or peer-reviewed data were published, and Perry says the follow-up scans were taken one week and six months after treatment, not the four to six weeks Rogan mentioned. Presenting it as settled proof that ibogaine reverses brain atrophy goes beyond the evidence. Published, independently read before and after scans showing the atrophy resolved would flip this verdict.
Read the supporting source · www.austinchronicle.com ↗Quick answer & review status
Quick answer
Is it true that Joe says Rick Perry's brain scans showed age-related atrophy before ibogaine and none six months later?
It leaves out the other side. Rogan's account matches what Perry himself says. A neuroscientist told Perry he had mild atrophy, and a neurosurgeon later looked at his before and after scans and said the atrophy was gone. Joe Rogan said it (matched by voice) on Joe Rogan Experience #2567 - Mariana van Zeller, aired Oct 16, 2026, at 2:18:19. The supporting source is austinchronicle.com, linked below.
The context belongs here.
No separately verified on-air correction is recorded for this check. That is not a claim that nobody corrected it.
- Attribution
- Not independently confirmed in this record
- Editorial context review
- Not recorded; generated finding
- Coverage
- One selected claim from the episode
Revisions to this check
No dated revision is recorded here. Older checks may predate this log.
Challenge this finding or add context →Keep the evidence coming.
Follow new checks in your RSS reader, or catch up with the weekly briefing on the site.
Email signup is currently unavailable.
Prefer to catch up here? Read the weekly briefing.